With the CBSE Class 12 Mathematics exam scheduled for March 9, 2026, students across the country are revising formulas and ...

Managing the money supply of a modern economy is a dirty job, but somebody has to do it. For some 110 years, we have had an operating central bank, the Federal Reserve system, to do that. It could ...

- 4Q 2025 net income available to common shareholders of $100.2 million, or $2.79 Earnings per Share ("EPS"). Full year 2025 net income available to common shareholders of $406.9 million, or $11.40 ...

Units into the sporting goods channel rose 28%, while adjusted NICS declined 2.2%, indicating market share gains. Long gun shipments -- Decreased 25% into the sporting goods channel with adjusted NICS ...

It's Election Day. Follow along for real-time results and turnout trends from Austin as Texas primary voting unfolds.

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer, will ...

Phase 2 third cohort (28 days, 15 mg) generally safe and well toleratedARCT-032 permitted to proceed into 12-week Phase 2 study; dosing to begin H1 2026Cash runway extended into Q2 2028Investor ...

Good morning, and welcome to the ImmuCell Corporation Conference Call to discuss Unaudited Fourth Quarter and Full Year 2025 Financial Results. [Operator Instructions] Please note, this event is being ...

I'd like to thank everyone for joining us today for the Inuvo Fourth Quarter and Full Year 2025 Shareholder Update Call. Today, Inuvo's Chief Executive Officer, Rob Buchner; and Chief Financial ...

Gentle yet powerful, peptide serums boost collagen, hydrate deeply, and deliver visible firmness. We tested the top picks ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data ...

Long-Term Effects of Ozempic This article was reviewed by Lynn Marie Morski, MD, JD. You may have heard about — or maybe even ...